In monkeys with early and advanced atherosclerosis, we examined responses to the three major vasoactive agonists that are released when platelets aggregate. Measurements were obtained in normal cynomolgus monkeys and in monkeys fed an atherogenic diet for 4+1, 9±1, and 19±1 months (mean± SEM). Morphometry of femoral and iliac arteries indicated that 4 months of atherogenic diet produced only slight intimal thickening, 9 months produced early lesions, and 19 months produced approximately 5-10 -fold greater intimal proliferation than did 9 months of atherogenic diet. Serotonin and adenosine 5'-diphosphate (ADP), which are endotheliumdependent agonists, and adenosine and phenylephrine, which are endothelium-independent agonists, were injected intra-arterially into the perfused hind limb. Thromboxane A2 analogue U46619 also was studied. Vasoconstrictor responses to serotonin were potentiated, and vasodilator responses to ADP were impaired by early and advanced atherosclerosis. In contrast, vasoconstrictor responses to phenylephrine and vasodilator responses to adenosine were similar in all groups. Vasoconstrictor responses to U46619 were potentiated by advanced atherosclerosis. Thus, vascular responses to serotonin, ADP, and thromboxane A2 are altered by atherosclerosis in a direction that would favor vasoconstriction when platelets aggregate. Furthermore, because responses to endothelium-dependent agonists are altered, these data suggest that endothelium is dysfunctional in early atherosclerosis. These findings may explain, in part, the propensity for exaggerated vasoconstriction even in arteries with minimal atherosclerotic lesions. (Circulation 1989;79:698-705) R ecent observations in patients' and experimental animals in vitro2-4 and in ViVO5, 6 suggest that atherosclerosis predisposes to vasospasm. Spasm often occurs at sites with only modest lesions as defined by angiography.7,8 Moreover, although coronary arteriograms may not reveal segmental narrowing due to atherosclerosis in vessel segments prone to spasm, there may be evidence at autopsy of minimal atherosclerosis in the segment of vessel at which spasm occurred.9
Effect of Early and Advanced Atherosclerosis
In monkeys with early and advanced atherosclerosis, we examined responses to the three major vasoactive agonists that are released when platelets aggregate. Measurements were obtained in normal cynomolgus monkeys and in monkeys fed an atherogenic diet for 4+1, 9±1, and 19±1 months (mean± SEM). Morphometry of femoral and iliac arteries indicated that 4 months of atherogenic diet produced only slight intimal thickening, 9 months produced early lesions, and 19 months produced approximately 5-10 -fold greater intimal proliferation than did 9 months of atherogenic diet. Serotonin and adenosine 5'-diphosphate (ADP), which are endotheliumdependent agonists, and adenosine and phenylephrine, which are endothelium-independent agonists, were injected intra-arterially into the perfused hind limb. Thromboxane A2 analogue U46619 also was studied. Vasoconstrictor responses to serotonin were potentiated, and vasodilator responses to ADP were impaired by early and advanced atherosclerosis. In contrast, vasoconstrictor responses to phenylephrine and vasodilator responses to adenosine were similar in all groups. Vasoconstrictor responses to U46619 were potentiated by advanced atherosclerosis. Thus, vascular responses to serotonin, ADP, and thromboxane A2 are altered by atherosclerosis in a direction that would favor vasoconstriction when platelets aggregate. Furthermore, because responses to endothelium-dependent agonists are altered, these data suggest that endothelium is dysfunctional in early atherosclerosis. These findings may explain, in part, the propensity for exaggerated vasoconstriction even in arteries with minimal atherosclerotic lesions. ( In this study, we tested two hypotheses. First, we tested the hypothesis that responses to the three major platelet products, ADP, thromboxane, and serotonin are altered by advanced atherosclerotic lesions in a direction that would favor vasoconstriction. Second, we tested the hypothesis that even minimal atherosclerotic lesions may alter vascular responses.
Methods

Monkeys
Four groups of adult male Malaysian cynomolgus monkeys were studied. Eight normal monkeys were fed commercial laboratory chow (Purina Monkey Chow, Ralston Purina, Richmond, Indiana). Eight monkeys were fed atherogenic diet, which contained cholesterol (1 mg/calorie) and fat (41% of total calories) for 4 ± 1 months (mean ± SEM) (hypercholesterolemic group). Ten monkeys were fed atherogenic diet for 9±1 months (early atherosclerotic group). Nine were fed an atherogenic diet for 19 ± 1 months (advanced atherosclerotic group). The monkeys weighed 6.5 ± 0.3 kg in the normal group, 6.1±0.4 kg in the hypercholesterolemic group, 6.2 ± 0.2 kg in the early atherosclerotic group, and 5.9 ± 0.4 kg in the advanced atherosclerotic group. None of the monkeys described in this study has been described in other papers. Two monkeys that were fed atherogenic diet for 9 and 12 months did not have lesions on histologic and morphometric analysis and thus were included in the hypercholesterolemic group. At intervals of 3-4 months, the monkeys were sedated with ketamine HCl (10 [10] [11] [12] [13] [14] [15] mm Hg, which indicates that vascular isolation was adequate. Baseline perfusion pressure of the hind limb was established by adjusting blood flow so that the perfusion pressure was similar to the animal's mean arterial pressure. The difference between iliac pressure and dorsal pedal pressure, at constant flow, indicates resistance of large arteries in the limb. The method has been described in detail previously. 6, 14, 15 Maximal vasodilator responses of the hind limb were produced by infusion of papaverine hydrochloride (Sigma Chemical, St. Louis, Missouri) at 2.5 mg/min i.a. Perfusion pressure was measured during baseline flow and 40% below baseline flow. Infusion of higher doses of papaverine (5 mg/min) usually did not produce a further decrease in perfusion pressure, which indicates that the vessels were dilated maximally to the stimulus. In those experiments in which further vasodilation was observed, pressure-flow determinations were repeated.
We studied effects of adenosine, ADP (adenosine 5'-diphosphate from equine muscle), phenylephrine (1 x 10-8 and 3 x 10-8 mol), and U46619 (1 x 10-9 and 3 x 10-9 mol) were injected as a 0.1 ml bolus into the iliac perfusion tubing. Injection of 0.1 ml of vehicle for all of the agonists had minimal hemodynamic effects. Maximal changes in perfusion pressure and pressure in dorsal pedal artery were measured after bolus injections.
Morphologic Studies
The monkeys were killed with intravenous potassium chloride. The iliac and femoral artery vessels were removed, examined for gross lesions, and fixed by immersion in 10% buffered formalin. Specimens were taken at standardized sites from the proximal and midsegment of the iliac artery and proximal and midsegment of the femoral artery as described previously.14 Histologic study was carried out on paraffin-embedded sections. Sections were stained with hematoxylin and eosin and Verhoeff-Van Gieson. The size of the intima and media were morphometrically determined with an image analyzer as described previously. Figure 1 . During maximal vasodilatation, perfusion pressure tended to be higher in atherosclerotic monkeys than in normal monkeys and early atherosclerotic monkeys, but differences in slope and intercept did not achieve statistical significance (p >0.05).
Responses to serotonin. Serotonin produced vasodilatation in the limb (reduction in iliac perfusion pressure) in normal and hypercholesterolemic monkeys (Figure 2 (Figure 2 ). Serotonin produced minimal constriction of the large artery segment in the limb of normal and hypercholesterolemic monkeys (Figure 3) . The response to serotonin was potentiated in monkeys with early atherosclerosis (p < 0.05 vs. normal monkeys). There was striking potentiation of constrictor responses in the group with advanced atherosclerosis (p<0.05 vs. normal monkeys).
Responses to phenylephrine. In contrast to augmented vasoconstrictor responses to serotonin in atherosclerotic monkeys, responses to phenylephrine tended to be less in hypercholesterolemic, early atherosclerotic, and atherosclerotic monkeys than in normal monkeys (Figure 4) . Phenylephrine produced modest constriction of large arteries of the limb in all groups, and responses were not significantly different ( Figure 5 ).
Responses to thromboxane. Vasoconstrictor responses to the thromboxane analogue were augmented in atherosclerotic monkeys ( Figure 6 ). Thromboxane analogue produced constriction of large arteries of the limb, and this response was potentiated in monkeys with advanced atherosclerosis ( Figure 7 ). Responses to thromboxane were not measured in hypercholesterolemic monkeys.
Responses to ADP and adenosine. ADP produced vasodilatation in the limb of normal monkeys (Figure 8 Endothelium appears to have a critical role in modulation of vascular responses to vasoactive substances that are released from aggregating platelets.18'22-25Adenine nucleotides account for vasodilator response to aggregation of platelets in vitro, whereas serotonin and thromboxane account for vasoconstriction in canine arteries.24 In a provocative experiment, arterial injury produced by angioplasty of the common carotid artery led to vasoconstriction, and there was a correlation between platelet deposition and degree of vasoconstriction.26 Atherosclerosis does not lead to loss of endothelium, but it nevertheless appears to increase responsiveness to serotonergic vasoconstrictor responses in vitro2 and in vivo,6 and impair vasodilator responses to aggregation of platelets27 probably in part by producing a functional defect in the endothelium.28 Thus, it seems reasonable that platelets may have an important role in the pathogenesis of vasospasm.
Considerations of Previous Studies
We have shown previously that vasoconstrictor responses to serotonin in the limb are augmented by atherosclerosis.6"15 In the previous experiments, the atherosclerotic lesions were moderately advanced because they consisted predominantly of fibrous plaques. In this study, we examined monkeys with similar moderately advanced lesions and also monkeys with early atherosclerosis in which the lesions consisted predominantly of fatty streaks.
Effects of thromboxane A2 or its stable analogue U46619 have not been compared in previous studies in the normal or atherosclerotic limb. A study in vitro of coronary vessels from pigs and dogs suggests that removal of endothelium does not alter constrictor responses to U46619.29 A recent report in coronary arteries of rabbits, however, suggests that endothelium may modulate constrictor responses to the stable thromboxane A2 analogue 9,11-epithio-11,12-methano-TxA2(StA2). 30 In the present study, phenylephrine, an endotheliumindependent agonist, produced similar constrictor responses in the hind limb in normal monkeys and in monkeys with advanced atherosclerosis. The finding that vasoconstrictor responses to thromboxane are potentiated in monkeys with advanced atherosclero- 31 In the present study, vasodilator responses to ADP were impaired by hypercholesterolemia and atherosclerosis. Because vasodilator responses to adenosine, which are not endothelium-dependent,32 were preserved in atherosclerotic monkeys, endothelial dysfunction, which has been shown with a bioassay for endothelium-derived relaxing factor in atherosclerotic rabbits,28 probably has an important role in impaired vasodilator responses to ADP in atherosclerotic monkeys.
ADP had minimal effects on large arteries in this study. Thus, impairment of vasodilator responses to ADP by hypercholesterolemia and atherosclerosis must occur in small vessels, which do not have atherosclerotic lesions. The calculation of resistance of small vessels indicates that resistance is distal to the dorsal pedal artery, but calculation does not allow for differentiation between resistance of small arteries, arterioles, and venules. Impairment by atherosclerosis of dilator responses to ADP in small vessels presumably occurs by impairment of endotheliumdependent relaxation in these vessels. This finding extends our previous studies, which suggest that responses of large arteries are altered by atherosclerosis,6'15 and it provides evidence of impaired endothelium-dependent responses in small vessels. 33 Shimokawa et al4'5 used a model of balloon denudation to evaluate responses of regenerated endothelium in vitro and after accelerating the development of atherosclerosis in vivo. Endothelium-dependent relaxation to aggregating platelets and serotonin is depressed in porcine coronary arteries with regenerated endothelium. Responses to platelet products in vivo were not examined in those studies. Our study extends the findings of the previous studies4'5 because we induced atherosclerosis by cholesterol feeding, and not by balloon injury, and examined responses to products of platelet aggregation in vivo.
Mechanisms ofAltered Vascular Responses
We considered the possibility that alteration of clearance of serotonin, by several mechanisms, may contribute to alteration of responses to serotonin in atherosclerotic monkeys. Platelets take up serotonin, but differences in inactivation of serotonin by platelets probably did not have a role in alteration of vascular responses to serotonin. Inactivation of serotonin by blood is relatively slow, with a half-life of 60-120 seconds.34 In contrast, the half-life of serotonin in vivo is about 7 seconds because serotonin is metabolized primarily by the pulmonary endothelium. 35 During transit of a bolus through the lung, uptake of serotonin by platelets is negligible.36 Also, aggregation of platelets by ADP, serotonin, or thromboxane probably does not occur during bolus injections, because the predicted max- 
